Rates of continuous and 7-day point prevalence abstinence did not differ between treatment conditions at the 6-month follow-up ; however , point prevalence abstinence was significantly higher for intervention ( 11.5 % ) compared with control ( 2 % ) participants at 4 months ( OR = 6.46 , p = .01 ) .